Renaissance Technologies - SCPHARMACEUTICALS INC ownership

SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 39 filers reported holding SCPHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of SCPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$569
-65.3%
55,886
-69.1%
0.00%
-50.0%
Q1 2023$1,642
+9.0%
180,986
-13.8%
0.00%0.0%
Q4 2022$1,506
-99.9%
209,986
+16.5%
0.00%0.0%
Q3 2022$1,175,000
+27.3%
180,286
-5.9%
0.00%
+100.0%
Q2 2022$923,000
-12.7%
191,586
+3.0%
0.00%0.0%
Q1 2022$1,057,000
+11.4%
186,086
-1.5%
0.00%0.0%
Q4 2021$949,000
-26.3%
188,986
-2.4%
0.00%
-50.0%
Q3 2021$1,287,000
-2.7%
193,586
-10.6%
0.00%0.0%
Q2 2021$1,323,000
+3.9%
216,486
+13.1%
0.00%0.0%
Q1 2021$1,273,000
-2.6%
191,386
-22.5%
0.00%
+100.0%
Q4 2020$1,307,000
-41.2%
247,086
-17.1%
0.00%
-50.0%
Q3 2020$2,221,000
-9.6%
298,079
-10.7%
0.00%0.0%
Q2 2020$2,456,000
+72.5%
333,686
+73.4%
0.00%
+100.0%
Q1 2020$1,424,000
+53.8%
192,486
+17.6%
0.00%0.0%
Q4 2019$926,000
+40.7%
163,677
+46.0%
0.00%0.0%
Q3 2019$658,000
+353.8%
112,131
+146.4%
0.00%
Q2 2019$145,00045,5000.00%
Other shareholders
SCPHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
5AM Venture Management, LLC 3,831,474$20,268,0006.83%
AIGH Capital Management LLC 637,322$3,372,0001.37%
Worth Venture Partners, LLC 162,875$862,0000.68%
Ikarian Capital, LLC 1,466,147$7,756,0000.34%
RA Capital Management 3,518,998$18,615,0000.26%
Orbimed Advisors 4,797,148$25,377,0000.22%
DAFNA Capital Management LLC 38,891$206,0000.06%
BOOTHBAY FUND MANAGEMENT, LLC 150,699$797,0000.03%
Alyeska Investment Group, L.P. 355,690$1,882,0000.03%
ALGERT GLOBAL LLC 13,860$73,0000.02%
View complete list of SCPHARMACEUTICALS INC shareholders